H2nanO

Case Study - Passive Treatment of Organoselenium

SHARE
Apr. 1, 2023
Courtesy ofH2nanO

Our SolarPass technology effectively eliminates highly-biovailable organoselenium compounds produced by biological Se treatment processes to non-hazardous levels.

  • Elimination of organoselenium to levels
  • Reduced aquatic toxicity risk by a factor of 10,000x

Most popular related searches